Neonc Technologies Holdings (NTHI) Shares Outstanding (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Shares Outstanding (Entity) of $24.8 million for Q1 2026, up 30.48% year-over-year from $19.0 million in Q1 2025, and up 12.89% quarter-over-quarter from $22.0 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Shares Outstanding (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Shares Outstanding (Entity) for 3 consecutive years, with $24.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 30.48% year-over-year to $24.8 million; the TTM figure through Mar 2026 stood at $24.8 million (up 30.48% YoY), while the FY2025 annual figure was $22.0 million, up 21.56% from the prior year.
- Shares Outstanding (Entity) grew to $24.8 million in Q1 2026 per NTHI's latest filing, from $22.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $24.8 million in Q1 2026 and bottomed at $16.6 million in Q1 2024.
- Historically, Shares Outstanding (Entity) has averaged $19.4 million across 3 years, with a median of $19.0 million in 2025.
- Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) grew 6.71% — and 2026, when it soared 30.48%.
- Neonc Technologies Holdings' Shares Outstanding (Entity) stood at $18.1 million in 2024, then increased by 21.56% to $22.0 million in 2025, then rose by 12.89% to $24.8 million in 2026.
- Business Quant data shows NTHI's Shares Outstanding (Entity) at $24.8 million in Q1 2026, $22.0 million in Q4 2025, and $19.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 24.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.66 Mn |
| Mar 31, 2026 | 23.29 Mn |
| Dec 31, 2025 | 19.40 Mn |
| Sep 30, 2025 | 19.21 Mn |
| Jun 30, 2025 | 19.03 Mn |
| Mar 31, 2025 | 18.14 Mn |
| Dec 31, 2024 | 17.34 Mn |
| Sep 30, 2024 | 17.92 Mn |
| Jun 30, 2024 | 16.64 Mn |
| Mar 31, 2024 | 16.56 Mn |